Bruce Jackson
Stock Analyst at Benchmark
(1.02)
# 3,888
Out of 5,129 analysts
124
Total ratings
29.2%
Success rate
-20.09%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CV CapsoVision | Maintains: Speculative Buy | $5 → $14 | $4.70 | +198.19% | 2 | Dec 31, 2025 | |
| ABT Abbott Laboratories | Initiates: Buy | $145 | $112.28 | +29.14% | 1 | Oct 10, 2025 | |
| BFRI Biofrontera | Maintains: Buy | $7 → $2.75 | $0.78 | +254.84% | 8 | May 19, 2025 | |
| HUMA Humacyte | Maintains: Buy | $17 → $14 | $1.05 | +1,233.33% | 15 | May 14, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $4.5 → $3 | $0.60 | +399.17% | 6 | May 13, 2025 | |
| CLNN Clene | Maintains: Buy | $84 → $33 | $4.42 | +646.61% | 8 | May 8, 2025 | |
| GNLX Genelux | Maintains: Speculative Buy | $25 → $23 | $2.42 | +850.41% | 7 | May 8, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $80 | $176.91 | -54.78% | 9 | Mar 26, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $11.50 | - | 8 | Jan 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $65 | $103.35 | -37.11% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $0.25 | - | 3 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $6.37 | +370.96% | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1.25 | $0.26 | +386.38% | 2 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $0.95 | +215.79% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $1.07 | +367.29% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $300 | $13.52 | +2,118.93% | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $60 | $1.37 | +4,279.56% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $0.26 | +6,324.79% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $0.79 | +2,926.86% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $0.43 | +1,064.69% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.16 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $17.30 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $3.16 | +25,216.46% | 1 | Aug 8, 2022 |
CapsoVision
Dec 31, 2025
Maintains: Speculative Buy
Price Target: $5 → $14
Current: $4.70
Upside: +198.19%
Abbott Laboratories
Oct 10, 2025
Initiates: Buy
Price Target: $145
Current: $112.28
Upside: +29.14%
Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7 → $2.75
Current: $0.78
Upside: +254.84%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $1.05
Upside: +1,233.33%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $4.5 → $3
Current: $0.60
Upside: +399.17%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84 → $33
Current: $4.42
Upside: +646.61%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25 → $23
Current: $2.42
Upside: +850.41%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $176.91
Upside: -54.78%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $11.50
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $103.35
Upside: -37.11%
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.25
Upside: -
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $6.37
Upside: +370.96%
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.26
Upside: +386.38%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $0.95
Upside: +215.79%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $1.07
Upside: +367.29%
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $300
Current: $13.52
Upside: +2,118.93%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $60
Current: $1.37
Upside: +4,279.56%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $0.26
Upside: +6,324.79%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $0.79
Upside: +2,926.86%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $0.43
Upside: +1,064.69%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.16
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $17.30
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $3.16
Upside: +25,216.46%